623
Views
28
CrossRef citations to date
0
Altmetric
Research Article

Characterizing methamphetamine withdrawal in recently abstinent methamphetamine users: a pilot field study

, M.D., , M.D., , M.S., , M.D., Ph.D. & , Ph.D.
Pages 131-136 | Published online: 11 Jan 2011

REFERENCES

  • Murray J. Psychophysiological aspects of amphetamine-methamphetamine abuse. J Psychol 1998; 132:227–237.
  • Rawson RA, Anglin MD, Ling W. Will the methamphetamine problem go away? J Addict Dis 2002; 21:5–19.
  • Kosten TR. Neurobiology of abused drugs. Opioids and stimulants. J Nerv Ment Dis 1990; 178:217–227.
  • Albertson TE, Derlet RW, Van Hoozen BE. Methamphetamine and the expanding complications of amphetamines. West J Med 1999; 170:214–219.
  • NACO. The Meth Epidemic in America. Washington, DC: The National Association of Counties, 2005.
  • APA. Diagnostic and Statistical Manual for Mental Disorders 2000. Washington, DC: APA, 2000.
  • Cantwell B, McBride AJ. Self-detoxification by amphetamine dependent patients: A pilot study. Drug Alcohol Depend 1998; 49:157–163.
  • Gossop MR, Bradley BP, Brewis RK. Amphetamine withdrawal and sleep disturbances. Drug Alcohol Depend 1982; 10:177–183.
  • Shoptaw SJ, Kao U, Heinzerling K, Ling W. Treatment for amphetamine withdrawal. Cochrane Database Syst Rev 2009; 2:CD003021.
  • Srisurapanont M, Jarusuraisin N, Kittirattanapaiboon P. Treatment of amphetamine withdrawal. Cochrane Database Syst Rev 2001; (4). CD003021.
  • McGregor C, Srisurapanont M, Jittiwutikarn J, Laobhripatr S, Wongtan T, White JM. The nature, time course and severity of methamphetamine withdrawal. Addiction 2005; 100:1320–1329.
  • Monroe RR, Drell HZ. Oral use of stimulants obtained from inhalers. J Am Med Assoc 1947; 135:909–915.
  • Hawks D, Mitcheson M, Ogborne A, Edwards G. Abuse of methylamphetamine. Br Med J 1969; 21:715–721.
  • Angrist B, Sudilovsky A. Central nervous system stimulants: Historical aspects and clinical effects. In Handbook of Psychopharmacology, Vol 11: Stimulants. Iversen SD, Iversen LL, Snyder SH, eds. New York, NY: Plenum Press, 1978; 99–165.
  • Kales A, Heuser G, Kales JD, Rickles WH, Jr, Rubin RT, Scharf MB, Ungerleider JT, Winters WD. Drug dependency. Investigations of stimulants and depressants. Ann Intern Med 1969; 70:591–614.
  • Trevisan LA, Boutros N, Petrakis IL, Krystal JH. Complications of alcohol withdrawal: Pathophysiological insights. Alcohol Health Res World 1998; 22:61–66.
  • Koob GF. Neurobiology of addiction: Toward the development of new therapies. Ann N Y Acad Sci 2000; 909:170–185.
  • Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatr 1960; 23:56–62.
  • Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959; 32:50–55.
  • Carskadon MA, Dement WC, Mitler MM, Guilleminault C, Zarcone VP, Spiegel R. Self-reports versus sleep laboratory findings in 122 drug-free subjects with complaints of chronic insomnia. Am J Psychiatry 1976; 133:1382–1388.
  • Reitan KM. The relation of the trail making test to organic brain damage. J Consult Psychol 1955; 19:393–394.
  • Kaplan E, Fein D, Morris R, Delis DC. WAIS-R as a Neuropsychological Instrument. Toronto, ON: Harcourt Brace Jovanovich, Inc., 1991.
  • Golden CJ. Stroop Color and Word Test. Wood Dale, IL: Stoelting Co., 1978.
  • Kalechstein AD, Newton TF, Green M. Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. J Neuropsychiatry Clin Neurosci 2003; 15:215–220.
  • Monterosso JR, Aron AR, Cordova X, Xu J, London ED. Deficits in response inhibition associated with chronic methamphetamine abuse. Drug Alcohol Depend 2005; 79:273–277.
  • Rawson R, Gonzales R, Brethen P. Treatment of methamphetamine use disorders: An update. J Subst Abuse Treat 2002; 23:145–50.
  • Vocci F. Medication development for methamphetamine-related disorders. Presented to the Methamphetamine Advisory Group to Attorney General Reno, Washington, DC, May 1998.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.